Zürcher Nachrichten - Once-taboo ketamine booms for US at-home mental care

EUR -
AED 4.190162
AFN 82.135427
ALL 99.363241
AMD 444.283963
ANG 2.055997
AOA 1046.652663
ARS 1343.832124
AUD 1.77551
AWG 2.056237
AZN 1.932993
BAM 1.966166
BBD 2.303947
BDT 138.639709
BGN 1.953904
BHD 0.429896
BIF 3345.876246
BMD 1.140769
BND 1.499278
BOB 7.901484
BRL 6.450363
BSD 1.141116
BTN 96.978582
BWP 15.642193
BYN 3.734222
BYR 22359.07754
BZD 2.292054
CAD 1.578077
CDF 3284.275012
CHF 0.937102
CLF 0.028062
CLP 1076.874961
CNY 8.321893
CNH 8.311753
COP 4810.623979
CRC 576.941701
CUC 1.140769
CUP 30.230385
CVE 110.5978
CZK 24.954899
DJF 202.737766
DKK 7.465457
DOP 67.305622
DZD 151.027578
EGP 58.001728
ERN 17.111539
ETB 149.550648
FJD 2.603406
FKP 0.856819
GBP 0.849411
GEL 3.125667
GGP 0.856819
GHS 17.465125
GIP 0.856819
GMD 80.994465
GNF 9873.357999
GTQ 8.788333
GYD 238.722293
HKD 8.848548
HNL 29.431933
HRK 7.534098
HTG 149.307164
HUF 404.328564
IDR 19166.691798
ILS 4.127418
IMP 0.856819
INR 97.14888
IQD 1494.978118
IRR 48040.649287
ISK 146.007378
JEP 0.856819
JMD 180.76141
JOD 0.808919
JPY 162.244805
KES 147.731395
KGS 99.760127
KHR 4566.499656
KMF 493.386381
KPW 1026.692336
KRW 1641.042437
KWD 0.349749
KYD 0.950997
KZT 585.190057
LAK 24683.369827
LBP 102212.926182
LKR 341.751753
LRD 227.64099
LSL 21.30462
LTL 3.368395
LVL 0.690039
LYD 6.242858
MAD 10.580087
MDL 19.54671
MGA 5147.719945
MKD 61.553306
MMK 2395.477676
MNT 4073.570578
MOP 9.116222
MRU 45.162707
MUR 51.619833
MVR 17.579546
MWK 1978.19458
MXN 22.352576
MYR 4.971243
MZN 73.008614
NAD 21.30462
NGN 1831.185579
NIO 41.991383
NOK 11.806653
NPR 155.166012
NZD 1.912066
OMR 0.439206
PAB 1.141091
PEN 4.182345
PGK 4.623565
PHP 64.362474
PKR 320.673116
PLN 4.267794
PYG 9137.172187
QAR 4.159191
RON 4.977976
RSD 117.831219
RUB 94.291218
RWF 1609.643891
SAR 4.279173
SBD 9.530343
SCR 16.496695
SDG 685.034147
SEK 10.947847
SGD 1.4939
SHP 0.896466
SLE 25.899685
SLL 23921.342521
SOS 651.952421
SRD 42.037662
STD 23611.620524
SVC 9.984552
SYP 14832.197421
SZL 21.121387
THB 38.078835
TJS 12.038155
TMT 3.992692
TND 3.402351
TOP 2.671797
TRY 43.857991
TTD 7.744695
TWD 37.014078
TZS 3068.668932
UAH 47.569776
UGX 4185.064123
USD 1.140769
UYU 48.042866
UZS 14772.962132
VES 98.730054
VND 29660.000818
VUV 137.556436
WST 3.153067
XAF 659.419079
XAG 0.034467
XAU 0.000342
XCD 3.082986
XDR 0.818879
XOF 656.505185
XPF 119.331742
YER 279.605762
ZAR 21.122997
ZMK 10268.29402
ZMW 31.864294
ZWL 367.327237
  • RIO

    0.3100

    60.87

    +0.51%

  • NGG

    0.8100

    72.85

    +1.11%

  • BTI

    0.3400

    42.39

    +0.8%

  • BCE

    0.1600

    21.81

    +0.73%

  • RBGPF

    -2.5700

    60.88

    -4.22%

  • SCS

    -0.0300

    9.86

    -0.3%

  • GSK

    0.6300

    38.06

    +1.66%

  • CMSC

    -0.0100

    22.32

    -0.04%

  • BCC

    -0.1800

    95.33

    -0.19%

  • BP

    -0.0600

    29.13

    -0.21%

  • AZN

    0.3600

    69.93

    +0.51%

  • VOD

    0.2200

    9.57

    +2.3%

  • JRI

    0.0600

    12.8

    +0.47%

  • RYCEF

    0.0300

    10.18

    +0.29%

  • CMSD

    0.0200

    22.48

    +0.09%

  • RELX

    -0.1900

    53.36

    -0.36%

Once-taboo ketamine booms for US at-home mental care
Once-taboo ketamine booms for US at-home mental care

Once-taboo ketamine booms for US at-home mental care

Americans are paying to get a star of the psychedelic medicine movement –- ketamine -– shipped to them for at-home mental health treatments that are being called both a breakthrough and a gamble.

Text size:

A pandemic-spurred easing of prescription rules helped fuel a jump in telemedicine offerings of ketamine, an anesthetic that was once a taboo party drug but has become a buzzed-about tool against depression.

Yet long-term, large-scale studies of ketamine's medical impact are limited, leaving some experts concerned that an unregulated online boom could result in mishaps or a regulatory crackdown.

"This has to be rolled out slowly," said Boris Heifets, a Stanford University assistant professor of anesthesiology. "The risk is that we are scaling the fix but not the solution, which is a much more integrated approach to mental health."

Ketamine has been available in the United States since the 1970s as an anesthetic called a "dissociative" because of the hallucinogenic effects that have helped make it a rave culture drug.

It's legal for US doctors to prescribe, while some other psychedelics getting renewed attention for mental health uses like LSD or MDMA (also called ecstasy) are classified as having no medical utility and a high risk for abuse.

In this context, recent years have seen an uptick in clinics offering in-person intravenous ketamine treatments for depression, anxiety or chronic pain, though regulations and practices vary across American states.

- Ketamine 'babysitter' -

Then came the pandemic, which resulted in US authorities allowing doctors to remotely prescribe drugs like ketamine that previously required an in-person visit.

An increasing number of companies, some already doing in-clinic treatments, began offering to evaluate clients online and to send the drugs for home use to approved candidates.

Nue Life, which launched about a year ago, is one of those firms. Its CEO Juan Pablo Cappello estimated it has served over 3,000 ketamine patients so far.

"If you actually drill down on the sort of potentials for abuse here, you realize of course they exist, but we're creating a standard of care to make that quite unlikely," he told AFP.

For example, he noted clients are instructed to have an adult "babysitter" watch over them for the roughly 90 minutes the drug experience lasts, and he reasoned that people simply looking for ketamine could get it cheaper on the street.

Clients of the service, which costs $1,250 for a package providing six ketamine experiences, are encouraged but not obligated to couple it with therapy, Cappello said.

"The at-home telemedicine model, I would argue, is actually safer and more effective for patients," allowing more patients "to actually take advantage of these therapies," he added.

Heifets, the Stanford researcher, noted that making ketamine more available carries risks -- including the chances that authorities would tighten access if an at-home treatment resulted in some sort of tragedy.

- 'Change your life' -

US regulators in 2019 approved a type of ketamine specifically for adults with treatment-resistant depression, though with stringent rules like requiring patients to be monitored by a health care provider for at least two hours after their dose.

Americans have "a hair trigger for problem-solving through litigation," Heifets noted of the potential for lawsuits if things go wrong.

He was part of a team that analyzed the real-world effectiveness of intravenous ketamine therapy -- which can involve higher doses than the at-home services –- and reported most patients improved, though about eight percent said depressive symptoms worsened after treatment.

"We have very, very little evidence for our understanding of how effective ketamine is for depression at scale," he added.

Yet for people like 36-year-old New Yorker Philip Markle, who underwent an at-home treatment with a company called Mindbloom, ketamine is a profoundly useful tool.

Over his long battle with depression, the performer and comedian has tried medication, psychedelics like LSD, and talk therapy since the age of 12, but found something unique in ketamine.

Rather than the short-lived sense of change other treatments provided, ketamine imparted a sense of clarity and of helpful self-acceptance -– not the heavy effects he'd experienced with other psychedelics.

"It felt like if any drug could be administered through the mail, and you could do a psychedelic that could change your life, on your own, this would be the one," he told AFP.

L.Muratori--NZN